Free Trial

HC Wainwright's Rating of NextNRG on 9/2/2025

On September 2, 2025, HC Wainwright updated its outlook on NextNRG (NASDAQ:NXXT) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
9/10/2025
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
Reiterated Rating
9/10/2025
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
Reiterated Rating
9/10/2025
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
Lower Price Target
9/10/2025
Agenus Inc. stock logo
AGEN
Agenus
Reiterated Rating
9/10/2025
Moleculin Biotech, Inc. stock logo
MBRX
Moleculin Biotech
Reiterated Rating
9/10/2025
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
Reiterated Rating
More Ratings From HC Wainwright